Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Due Larsen

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Alimentary Pharmacology & Therapeutics|September 19, 2019
Editorial: anti-TNF therapy-a double-edged sword? Authors' replyJoshua Korzenik, Michael Due Larsen, Jan Nielsen, et al.
Inflammatory Bowel Diseases|December 10, 2015
Postoperative Use of Anti-TNF-α Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort StudyJens Kjeldsen, Jan Nielsen, Michael Due Larsen, et al.
Alimentary Pharmacology & Therapeutics|July 4, 2019
Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel diseaseJoshua Korzenik, Michael Due Larsen, Jan Nielsen, et al.
Annals of the Rheumatic Diseases|January 14, 2019
Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort studyBente Mertz Nørgård, Michael Due Larsen, Sonia Friedman, et al.
European Journal of Epidemiology|April 2, 2021
The Danish National Register of assisted reproductive technology: content and research potentialsLine Riis Jølving, Karin Erb, Bente Mertz Nørgård, et al.
Clinical Epidemiology|September 10, 2019
The chance of a live birth after assisted reproduction in women with thyroid disordersLine Riis Jølving, Michael Due Larsen, Jens Fedder, et al.
BMC Palliative Care|March 14, 2025
Emergency palliative cancer care: anxiety and midazolamMorten Tranung, Tora S Solheim, Erik Torbjørn Løhre, et al.
Journal of Clinical Medicine|February 24, 2024
Longitudinal Measurements of Blood Biomarkers in Patients with Crohn's Disease or Ulcerative Colitis Treated with Infliximab: Only the Latest Values in the Induction Period Predict Treatment FailureKim Oren Gradel, Bente Mertz Nørgård, Sonia Friedman, et al.
Diabetologia|June 18, 2020
Live-born children after assisted reproduction in women with type 1 diabetes and type 2 diabetes: a nationwide cohort studyMichael Due Larsen, Dorte Møller Jensen, Jens Fedder, et al.
BMC Family Practice|October 13, 2018
General practitioners' continuation and acceptance of medication changes at sectorial transitions of geriatric patients - a qualitative interview studyAnja G Strehlau, Michael Due Larsen, Jens Søndergaard, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Alimentary Pharmacology & Therapeutics|September 19, 2019
Editorial: anti-TNF therapy-a double-edged sword? Authors' replyJoshua Korzenik, Michael Due Larsen, Jan Nielsen, et al.
Inflammatory Bowel Diseases|December 10, 2015
Postoperative Use of Anti-TNF-α Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort StudyJens Kjeldsen, Jan Nielsen, Michael Due Larsen, et al.
Alimentary Pharmacology & Therapeutics|July 4, 2019
Increased risk of developing Crohn's disease or ulcerative colitis in 17 018 patients while under treatment with anti-TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel diseaseJoshua Korzenik, Michael Due Larsen, Jan Nielsen, et al.
Annals of the Rheumatic Diseases|January 14, 2019
Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort studyBente Mertz Nørgård, Michael Due Larsen, Sonia Friedman, et al.
European Journal of Epidemiology|April 2, 2021
The Danish National Register of assisted reproductive technology: content and research potentialsLine Riis Jølving, Karin Erb, Bente Mertz Nørgård, et al.
Clinical Epidemiology|September 10, 2019
The chance of a live birth after assisted reproduction in women with thyroid disordersLine Riis Jølving, Michael Due Larsen, Jens Fedder, et al.
BMC Palliative Care|March 14, 2025
Emergency palliative cancer care: anxiety and midazolamMorten Tranung, Tora S Solheim, Erik Torbjørn Løhre, et al.
Journal of Clinical Medicine|February 24, 2024
Longitudinal Measurements of Blood Biomarkers in Patients with Crohn's Disease or Ulcerative Colitis Treated with Infliximab: Only the Latest Values in the Induction Period Predict Treatment FailureKim Oren Gradel, Bente Mertz Nørgård, Sonia Friedman, et al.
Diabetologia|June 18, 2020
Live-born children after assisted reproduction in women with type 1 diabetes and type 2 diabetes: a nationwide cohort studyMichael Due Larsen, Dorte Møller Jensen, Jens Fedder, et al.
BMC Family Practice|October 13, 2018
General practitioners' continuation and acceptance of medication changes at sectorial transitions of geriatric patients - a qualitative interview studyAnja G Strehlau, Michael Due Larsen, Jens Søndergaard, et al.
Pageof 5